Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HepaStem in Paediatric UCD and CN
NCT01765283Phase 2Completed
- Sponsor
- Cellaïon
- Start
- Mar 2012
- Primary completion
- Oct 2014
- Modality
- Mesenchymal Stem Cells
- Countries
- 5
01
Overview
A Phase 2 trial of hepastem in urea cycle disorders (UCD), Crigler-Najjar syndrome (CNS), sponsored by Cellaïon. Started Mar 2012; status: completed.
02
Drugs
hepastem
03
Conditions
urea cycle disorders (UCD)Crigler-Najjar syndrome (CNS)
Beyond the preview
Go deeper on NCT01765283.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01765283.